The Japanese pharmaceutical giant Takeda has announced that it will invest €300 million in its branch in Lessines, Hainaut province.
The site is already used to process blood plasma into treatments for rare diseases. Takeda now plans to build a new production facility and warehouse, worth an investment of €300 million. It is Takeda’s largest investment ever in Belgium.
The investment was announced on the occasion of the site’s fiftieth anniversary.
With the investment, Takeda “confirms Belgium’s importance as a strategic location for the worldwide production and distribution of plasma-derived therapies,” the company said in a press release.
Takeda’s factory is located in Lessines in Hainaut, close to the border with Flanders. More than 1,200 people work there, many of them Flemish. More than 300,000 patients can be treated annually thanks to the treatments made in Lessines.